keyword
MENU ▼
Read by QxMD icon Read
search

Diphereline

keyword
https://www.readbyqxmd.com/read/29765929/gonadotropin-releasing-hormone-agonist-plus-aromatase-inhibitor-in-the-treatment-of-uterine-leiomyoma-in-near-menopause-patient-a-case-series-study
#1
Sanam Moradan
Objectives: There are many drugs for of symptomatic fibroids. Gonadotropin-releasing hormone (GnRH) agonists are the well known drugs. Also, aromatase inhibitors are effective. All published studies surveyed the effect of one of these two drugs. In this study as the first study decided to evaluate the effectiveness of the combination of GnRH agonists + aromatise inhibitor on the uterine fibroids. Methods: A cross-sectional prospective case series study was performed on 10 known cases of uterine fibroids late perimenopause, at least 3 myomas >5 cm, abnormal uterine bleeding and anemia due to fibroids, candidate for hysterectomy, no tendency to surgery...
April 2018: Journal of Menopausal Medicine
https://www.readbyqxmd.com/read/27829826/evaluate-the-effectiveness-of-conservative-treatment-for-menorrhagia-in-women-who-were-admitted-to-the-shahid-sadoughi-hospital-of-yazd-iran-in-2014-2015
#2
M Karimi-Zarchi, M Zaid Abadinezhad, B Bonyadpour, S Kabyrpour-Ashkezar, A M Abhaji
BACKGROUND AND AIM: Abnormal uterine bleeding is one of the most common debilitating menstrual problems. The first therapeutic strategy for abnormal uterine bleeding is drug treatment. This study was, therefore, designed to determine the efficacy of megestrol, medroxyprogesterone, GnRh agonist, Levonorgestrol IUD and endometrial ablation on bleeding and also to evaluate the side effects of each methods in patients with menorrhagia who were admitted to the Shahid Sadoughi clinic of Yazd University of Medical Sciences...
September 2016: International Journal of Biomedical Science: IJBS
https://www.readbyqxmd.com/read/27141469/ovarian-malignant-mixed-germ-cell-tumor-a-case-of-unusual-presentation-as-molar-pregnancy
#3
Soheila Aminimoghaddam, Iman Mohseni, Azadeh Afzalzadeh, Shooka Esmaeeli
BACKGROUND: This research was conducted to introduce a patient with rare ovarian mixed germ cell tumor, presented as molar pregnancy. CASE PRESENTATION: The patient was a 16 year old woman admitted with diagnosis of molar pregnancy. Abdominal enlargement was the only complaint. She had a large pelvic mass in physical examination. The first diagnosis was molar pregnancy due to previous ultrasonic reports and positive βeta HCG. Urine pregnancy test was positive. As suction curettage was performed for her, surprisingly, the size of uterus was normal and no molar tissue was found in pathologic examination...
April 2016: Journal of Reproduction & Infertility
https://www.readbyqxmd.com/read/26675055/comparative-study-of-vaginal-danazol-vs-diphereline-a-synthetic-gnrh-agonist-in-the-control-of-bleeding-during-hysteroscopic-myomectomy-in-women-with-abnormal-uterine-bleeding-a-randomized-controlled-clinical-trial
#4
RANDOMIZED CONTROLLED TRIAL
M Sayyah-Melli, S Bidadi, S Taghavi, E Ouladsahebmadarek, M Jafari-Shobeiri, M Ghojazadeh, V Rahmani
OBJECTIVE: To compare the usefulness of vaginal danazol and diphereline in the management of intra-operative bleeding during hysteroscopy. DESIGN: Randomized controlled clinical trial. SETTING: University hospital. PATIENTS: One hundred and ninety participants of reproductive age were enrolled for operative hysteroscopy. Thirty women were excluded from the study. INTERVENTIONS: One hundred and sixty participants with submucous myomas were allocated at random to receive either vaginal danazol (200mg BID, 30 days before surgery) or intramuscular diphereline (twice with a 28-day interval)...
January 2016: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://www.readbyqxmd.com/read/26290848/comparison-of-the-efficacy-of-two-brands-of-triptorelin-microrelin-and-diphereline-in-reducing-prostate-specific-antigen-and-serum-testosterone-in-prostate-cancer-a-double-blinded-randomized-clinical-trial
#5
Farid Fazeli, Mohammad Reza Nowroozi, Mohsen Ayati, Sahar Latifi, Mohsen Taheri Mahmoodi, Abbas Norouzi Javidan, Hassan Jamshidian, Amir Arbab
BACKGROUND: Gonadotropin-releasing hormone (GnRH) agonists initiate androgen deprivation in treating prostate cancer (PC). Triptorelin is a synthetic GnRH and many of its market brands such as Diphereline have been introduced so far. OBJECTIVES: We compared the efficacy of a sustained-release formulation of Triptorelin (Microrelin), domestically produced in Iran, and compared it with Diphereline in a double-blinded randomized clinical trial. PATIENTS AND METHODS: Patients were randomly assigned to Group A (Microrelin S...
May 2015: Nephro-urology Monthly
https://www.readbyqxmd.com/read/25056469/self-control-study-on-reduced-dose-depot-versus-daily-administration-of-gonadotrophin-releasing-hormone-agonists-for-pituitary-desensitization-in-in-vitro-fertilization-cycles
#6
COMPARATIVE STUDY
Jun Gao, Yan-Wen Xu, Ben-Yu Miao, Can-Quan Zhou
AIM: Our aim was to analyze the effect of reducing the dose of depot gonadotrophin-regulating hormone-agonist (GnRH-a) to 1.0 mg on pituitary desensitization and clinical outcome of in vitro fertilization and embryo transfer cycles. MATERIAL AND METHODS: This retrospective self-control study was conducted on 143 patients who underwent repeated long-protocol treatment from 1 January 2011 to 31 May 2012 at our hospital. Of the 143 patients, 64 received reduced-dose depot (1...
July 2014: Journal of Obstetrics and Gynaecology Research
https://www.readbyqxmd.com/read/24654464/evaluation-of-the-effect-of-gnrh-agonist-on-menstrual-reverse-in-breast-cancer-cases-treated-with-cyclophosphamide
#7
M Karimi-Zarchi, M Forat-Yazdi, M R Vafaeenasab, M Nakhaie-Moghadam, A Miratashi-Yazdi, S Teimoori, A Dehghani-Tafti
UNLABELLED: Twenty-five percent of breast cancer cases are detected during premenopausal period and the number of young women suffering from breast cancer is increasing in the world, especially in Iran. Preservation of fertility and ovarian function leads to improved quality of life of these patients. The aim of this study was to evaluate the effect of gonadotropin releasing hormone (GnRH) agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide regimen. MATERIALS AND METHODS: This randomized clinical trial (RCT) was conducted on 42 adenocarcinoma cases...
2014: European Journal of Gynaecological Oncology
https://www.readbyqxmd.com/read/23456583/the-side-effects-of-gonadotropin-releasing-hormone-analog-diphereline-in-treatment-of-idiopathic-central-precocious-puberty
#8
Zohreh Karamizadeh, Mahmoodreza Tabebordbar, Forough Saki, Hamdollah Karamifar, Gholamhossein Amirhakimi
Treatment of central precocious puberty (CPP) is the administration of GnRH analogs. Metabolic syndrome comprised metabolic disturbances that confer increased risk of (CVD) diabetes mellitus (DM) and cardiovascular disease. This study is a longitudinal prospective study in pediatric endocrinology clinic. 30 non-obese children with idiopathic CPP were involved. Total body weight, height, blood pressure, BMI and waist circumference of the patients along with their triglyceride (TG), total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL), fasting plasma sugar (FPS) were evaluated at the beginning and during 3 and 6 months GnRH analog therapy...
2013: Acta Medica Iranica
https://www.readbyqxmd.com/read/23324190/-clinical-applications-of-different-doses-of-leuprorelin-acetate-in-in-vitro-fertilization-embryo-transfer
#9
Li Wang, Wen-xiang Zhang, Hong Jiang
OBJECTIVE: To evaluate the clinical effect of different doses of leuprorelin acetate in in vitro fertilization-embryo transfer (IVF-ET). METHODS: From January 2011 to December 2011, the data of 268 patients undergoing IVF and(or) intracytoplasmic sperm injection (ICSI) in Reproductive Medical Center, Clinical College of PLA, Anhui Medical University were studied retrospectively. All the patients were divided into three groups based on with long protocol and controlled ovarian stimulation (COH) including 83 cycles with 1...
December 2012: Zhonghua Fu Chan Ke za Zhi
https://www.readbyqxmd.com/read/22427771/half-dose-long-acting-gonadotropin-releasing-hormone-agonist-diphereline-is-comparable-with-daily-injections-of-short-acting-gonadotropin-releasing-hormone-agonist-suprefact-in-ivf-icsi-cycles
#10
Ensieh Sh Tehraninejad, Elham Azimi Nekoo, Zahra Ezabadi, Batool H Rashidi, Elham Amirchaghmaghi, Elham Pour Matroud
INTRODUCTION: The aim of the study was to compare the efficacy of half-dose, long-acting GnRH analogue (Diphereline) with Suprefact in IVF/ICSI (in vitro fertilization/intracytoplasmic sperm injection) cycles. MATERIAL AND METHODS: In this randomized clinical trial performed in Royan Institute, 126 infertile women who were first time candidates for IVF/ICSI were enrolled. Patients were randomly divided into two groups by using a random number table. In one group, 62 patients received a single half dose, 1...
December 2010: Archives of Medical Science: AMS
https://www.readbyqxmd.com/read/21946260/formulation-and-evaluation-of-an-in-situ-gel-forming-system-for-controlled-delivery-of-triptorelin-acetate
#11
Sh Abashzadeh, R Dinarvand, M Sharifzadeh, G Hassanzadeh, M Amini, F Atyabi
The novel physical hydrogels composed of chitosan or its water soluble derivatives such as carboxymethyl chitosan (CMCh) and sodium carboxymethyl chitosan (NaCMCh) and opened ring polyvinyl pyrrolidone (OP-PVP) were used as a controlled delivery system for triptorelin acetate, a luteinizing-releasing hormone agonist. The in situ gel forming system designed according to physical interactions such as chains entanglements and hydrophilic attractions especially h-bonds of chitosan and/or NaCMCh and OR-PVP. In order to increase in situ gel forming rate the chitosan microspheres prepared through spray drying technique...
November 20, 2011: European Journal of Pharmaceutical Sciences
https://www.readbyqxmd.com/read/19668882/comparison-of-the-effect-of-gonadotropin-releasing-hormone-agonist-and-dopamine-receptor-agonist-on-uterine-myoma-growth-histologic-sonographic-and-intra-operative-changes
#12
RANDOMIZED CONTROLLED TRIAL
Manizheh Sayyah-Melli, Sepideh Tehrani-Gadim, Ali Dastranj-Tabrizi, Fatemeh Gatrehsamani, Ghojazadeh Morteza, Elaheh Ouladesahebmadarek, Laya Farzadi, Maryamalsadat Kazemi-Shishvan
OBJECTIVE: To investigate the effect of 2 medications; Diphereline and Cabergoline, on uterine leiomyoma growth, and its histologic, sonographic, and intra-operative changes. METHODS: In an effort to treat large uterine leiomyoma in symptomatic patients in the Gynecology Clinics of the Alzahra Teaching Hospital of Tabriz University of Medical Sciences, Tabriz, Iran, from September 2007 to November 2008, 60 candidates randomized to receive Diphereline 3.75 mg, 4 times every 28 days (group I), and Cabergoline 0...
August 2009: Saudi Medical Journal
https://www.readbyqxmd.com/read/19239796/-precocious-puberty-due-to-hypothalamic-hamartoma
#13
Magdalena Luba, Artur Bossowski, Justyna Kulikowska, Mirosława Urban, Maria Szarras-Czapnik, Robert Rutkowski, Tomasz Parol, Tomasz Gasiorek, Beata Sawicka, Marcin Skrzydło
INTRODUCTION: Central precocious puberty is usually idiopathic. Appearance of the precocious puberty symptoms in early childhood or pre-school period indicate that also it could be caused by organic disorder of the central nervous system. The aim of this work is to present the case of the 4-year-old girl, diagnosed with precocious puberty. THE CASE REPORT: The first clinical symptoms of precocious puberty such as increased growth rate and breast enlargement were observed when the girl was 4 years old...
2008: Pediatric Endocrinology, Diabetes, and Metabolism
https://www.readbyqxmd.com/read/17345767/-making-of-the-animal-model-with-sterilized-testes
#14
Feng-hua Liu, Dong-zi Yang, Yi-feng Wang, Xiao-ping Liang, Wen-ming Peng, Chang-an Cao, Xi-gu Chen, Zhong-min Guo
OBJECTIVE: To explore the methods of making an animal model with sterilized testes. METHODS: (1) X-ray local irradiation. Seventy 8-10-week-old male mice were equally divided into 6 experiment groups and a control group. The testes of the mice in the 6 experiment groups were irradiated sequentially by 1000, 1200, 1400, 1600, 1800 and 2000 cGy X-ray for 10 minutes, while those in the control group remained untreated. And then the pregnancy test was performed. (2) Cyclophosphamide injection...
February 2007: Zhonghua Nan Ke Xue, National Journal of Andrology
https://www.readbyqxmd.com/read/17334477/comparison-of-the-effect-of-gonadotropin-releasing-hormone-analog-diphereline-and-cabergoline-dostinex-treatment-on-uterine-myoma-regression
#15
RANDOMIZED CONTROLLED TRIAL
Manizheh Sayyah Melli, Laya Farzadi, Elaheh O S Madarek
OBJECTIVE: To investigate the effect of cabergoline (Dostinex, a dopamine agonist) on the myoma growth compared to Diphereline (a gonadotropin-releasing hormone agonist). METHODS: This study took place in the Department of Obstetrics and Gynecology of Tabriz University of Medical Sciences, Tabriz, Iran from July 2004 to December 2005. Fifty women with uterine myoma, who met the criteria of the study thoroughly, were randomly allocated into 2 equal groups to take either Diphereline or Cabergoline...
March 2007: Saudi Medical Journal
https://www.readbyqxmd.com/read/16813276/-precocious-puberty-and-von-recklinghausen-s-disease
#16
Ewa Barg, Beata Wikiera, Aleksander Basiak, Ewa Głab
Von Recklinghausen's disease belongs to a group of neurocutaneous syndromes and is characterised by skin, nerve and bone abnormalities. We present a case of von Recklinghausen's disease and precocious puberty in 7-year-old boy. At the age of three café au lait spots on the skin and an incranial tumour situated near the optic chiasm--qualified as inoperable--were discovered. At the age of 7 first signs of precocious puberty appeared (pubic hair P3 and enlargement of the testes (15 ml) and penis). Laboratory measurements included: LH 7...
2006: Wiadomości Lekarskie: Organ Polskiego Towarzystwa Lekarskiego
https://www.readbyqxmd.com/read/16607747/-specifics-of-therapy-of-tubal-infertility-in-patients-with-endometriosis
#17
Simina Vegheş, Ivona Lupaşcu, Cristina David, Valeria Vişan, Veronica Vasiliu
Our purpose was to define the best way of treating tubal infertility caused by endometriosis. We have studied 24 patients with tubal infertility caused by endometriosis; the etiology has been laparoscopically established in the 2nd Clinic of Obstetrics and Gynecology Iaşi. The endometriosis score (r-AFS) was used to establish the therapy. We performed laparoscopic treatment when endometriosis was visible. Postoperative medical therapy (Diphereline, 3 months) was indicated; patients with ,,unpigmented endometriosis" received the same medical therapy...
July 2005: Revista Medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti Din Iaş̧i
https://www.readbyqxmd.com/read/16059976/-relationship-between-serum-dehydroepiandrosterone-levels-and-female-precocious-puberty
#18
You-jun Jiang, Li-qin Chen, Li Liang, Chao-chun Zou, Hong Zhu, Jun-fen Fu, Zheng-yan Zhao
OBJECTIVE: To investigate the relationship of serum dehydroepiandrosterone (DHEA) levels and female precocious puberty. METHODS: The serum levels of DHEA and dehydroepiandrosterone sulfate (DHEAS) were measured by ELISA in 60 idiopathic central precocious puberty (ICPP) girls, 62 premature thelarche (PT) girls and 31 age-matched health prepuberty girls. Bone age,volume of uterus and ovary, DHEA and DHEAS were re-measured in 3, 12 months after treatment with Diphereline in ICPP girls...
July 2005: Zhejiang da Xue Xue Bao. Yi Xue Ban, Journal of Zhejiang University. Medical Sciences
https://www.readbyqxmd.com/read/16052045/-results-of-application-of-high-daily-doses-of-recombinant-follicle-stimulating-hormone-in-different-age-groups-of-women-in-ivf-program
#19
RANDOMIZED CONTROLLED TRIAL
G G Tsagareishvili, N L Khonelidze, A P Lazarev
A prospective, randomized, comparative study has been carried out to investigate the effectiveness of administration of recombinant FSH (rFSH, Gonal-F) in doses 150 and 225 IU in different age groups of women. 63 patients started a long gonadotrophin-releasing hormone agonist protocol (GnRHa, Diphereline, 0,1 mg): 31 received rFSH 150 IU/day and 32 - 225 IU/day. The objective was to assess the impact of these dosing regimens in down-regulated women. Duration of treatment for reaching administered criteria for human chorionic gonadotropin (HCG, Profazi) showed that the results in low-dose group and high-dose group were similar (11,8+/-0,2 days versus 11,2+/-0,4 days)...
June 2005: Georgian Medical News
https://www.readbyqxmd.com/read/15918263/-hormonal-suppression-and-sexual-development-in-children-with-central-precocious-puberty-in-the-first-treatment-cycle-12-weeks-after-injection-of-triptoreline-11-25-mg-diphereline-s-r-11-25-mg-a-pilot-study
#20
M Snajderová, D Zemková, L Teslík, M Pechová, R Vetesníková-Koubová, H Mlcochová, J Vavrinec
OBJECTIVE: To evaluate hormonal suppression and pubertal development in children with central precocious puberty (CPP) after injection of triptoreline 11.25 mg (Diphereline S. R. 11.25 mg; Ipsen) in the first treatment cycle of 12 weeks. DESIGN: Pilot study. SETTING: Paediatric department, University Hospital Motol-Prague. METHODS: Serum levels of FSHmax and LHmax and basal levels of estradiol/testosterone were monitored in GnRH test before, 4, 8 and 12 weeks after triptoreline 11...
March 2005: Ceská Gynekologie
keyword
keyword
163303
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"